Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

viiv_healthcare

ViiV completes BMS HIV pipeline purchase

February 23, 2016 Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, GSK, HIV, Pfizer, Shionogi, ViiV

ViiV Healthcare has completed its previously-announced acquisition of Bristol-Myers Squibb’s late-stage HIV R&D assets and its portfolio of preclinical and …
News
fda

Califf clears key hurdle to FDA top job

February 23, 2016 Manufacturing and Production, Medical Communications, Research and Development

Dr Robert Califf, President Obama’s nominee to head up the US Food and Drugs Administration as commissioner, has edged a …
News

Europe approves Bayer haemophilia drug

February 22, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, haemophilia a

Bayer has received approval from the European Commission for its haemophilia A drug Kovaltry (octocog alfa) in patients of all …
News
pharmafocus_march_front_cover

March edition of Pharmafocus live

February 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The March 2016 edition of Pharmafocus is now live and available to read here.
News
amgen_ucb

Amgen and UCB announce positive romosozumab results

February 22, 2016 Medical Communications, Research and Development, Sales and Marketing Amgen, Romosozumab, UCB, osteoporosis

Romosozumab development partners Amgen and UCB have announced positive top-line results from a Phase III study of the drug in postmenopausal …
News
sanofi

FDA to decide on Sanofi diabetes combo

February 22, 2016 Research and Development, Sales and Marketing Lantus, Sanofi

Sanofi will be looking to August for a decision on its new type 2 diabetes combo LixiLan (lixisenatide and Lantus), …
News
novartis_pic

Novartis drug PKC412 gets Breakthrough designation for AML

February 19, 2016 Medical Communications, Research and Development FDA, Novartis, acute myeloid leukaemia

Novartis’ PKC412 (midostaurin)  has become the latest in a sequence of FDA Breakthrough Therapy designations awarded this week- bagging the …
News

More evidence required for Alexion’s Kanuma, says NICE

February 18, 2016 Medical Communications, Research and Development Alexion, Kanuma, LAL-D, rare diseases

NICE says it needs additional trial data before it can recommend Alexion’s enzyme replacement therapy Kanuma (sebelipase alfa) for the …
News
antibiotics

Give GPs feedback on prescribing habits to reduce antibiotic use, says study

February 18, 2016 Medical Communications, Research and Development antimicrobial resistance

A trial of more than 1,500 GP practices has shown that sending general practitioners (GPs) letters giving feedback on their …
News
gilead-sciences

FDA approves Gilead’s Harvoni in two new indications

February 18, 2016 Research and Development Gilead Sciences, MSD, harvoni, hepatitis C

The hepatitis C treatment battle had its latest development yesterday, with the FDA awarding Gilead Science’s market-leading drug Harvoni (ledipasvir/sofosbuvir) …
News
az_logo_on_building

AZ’s durvalumab awarded breakthrough status in bladder cancer

February 18, 2016 Research and Development AstraZeneca, FDA, bladder cancer

AstraZeneca, and its biologics/R&D arm MedImmune, have won FDA Breakthrough Therapy status for their bladder cancer drug durvalumab (MEDI4736), which …
News

Pfizer pays $784m to settle Protonix overcharge claims

February 17, 2016 Research and Development, Sales and Marketing Medicaid, Pfizer, Wyeth, protonix

US drugs giant Pfizer is to pay more than $784 million to settle claims that it overcharged health insurer Medicaid …
News

FDA gives Roche MS drug breakthrough status

February 17, 2016 Research and Development Genentech, MS, Roche

Roche subsidiary Genentech has been awarded US Food and Drug Administration (FDA) Breakthrough Therapy Designation for its drug Ocrevus (ocrelizumab) …
News
image_via_the_dementia_consortium

AbbVie becomes Dementia Consortium’s latest pharma partner

February 16, 2016 Manufacturing and Production, Research and Development

AbbVie has become the latest pharmaceutical company to join The Dementia Consortium- a £4 million global collaboration aiming to speed …
News
brexit

What would BREXIT mean for pharma?

February 16, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing research and development

It began with a promise to UK voters to end ‘benefit tourism’ and to negotiate more flexibility in the UK’s …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025